Zum Inhalt

Dietary footprints of a global parasite: diagnosing Dibothriocephalus nihonkaiensis in non-endemic regions

  • Open Access
  • 01.12.2025
  • Case Report
Erschienen in:

Abstract

Background

Species within the genus Dibothriocephalus/Diphyllobothrium are notable for being among the largest cestodes capable of human infection. Historically, Dibothriocephalus latus (previously Diphyllobothrium latus) is considered the more prevalent species (in Europe and Patagonia). However, Dibothriocephalus nihonkaiensis (previously Diphyllobothrium nihonkaiensis) is commonly found in East Asian countries, particularly Japan, where diets frequently include raw salmons. The increasing globalization and adoption of diverse dietary practices have led to the detection of tapeworm infections like D. nihonkaiensis outside their traditionally endemic areas, potentially making them more common than previously thought, as exemplified by the present case in Singapore.

Case presentation

A 35-year-old Chinese female presented with chronic abdominal distension, loose stools and unintentional weight loss. 3 months prior to her symptom onset, she had travelled extensively throughout Asia (Thailand, Vietnam, Laos, Malaysia and China) and Mexico and had consumed raw salmon throughout her travels. A full blood count revealed eosinophilia, and a worm was passed during bowel preparation. Molecular sequencing identified it as D. nihonkaiensis. She was treated successfully with praziquantel.

Conclusion

Increased globalization, cross-cultural dietary exchange, and greater salmon consumption have expanded the geographic distribution of D. nihonkaiensis infections beyond previously endemic regions. Consequently, clinicians worldwide must maintain a high index of suspicion for this parasitic infection, even in non-endemic areas. A thorough patient history, with particular attention to dietary habits and travel, is paramount for accurate and timely diagnosis, thereby enabling appropriate treatment and preventing potential complications. Increased awareness, reporting, and molecular identification of Dibothriocephalus are crucial for determining infection sources and guiding food safety surveillance.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Dietary footprints of a global parasite: diagnosing Dibothriocephalus nihonkaiensis in non-endemic regions

Wilson G.W. Goh1  , Jean-Marc Chavatte2  , Gabriel Z.R. Yan1, 2, 3  , Yuan Yi Constance Chen4  , Mark Dhinesh Muthiah5   and Lionel H.W. Lum1  
Gut Pathogens202517:64

DOI: 10.1186/s13099-025-00738-9

Received: 3 May 2025

Accepted: 7 August 2025

Published: 21 August 2025

Background

Species within the genus Dibothriocephalus/Diphyllobothrium are notable for being among the largest cestodes capable of human infection. Historically, Dibothriocephalus latus (previously Diphyllobothrium latus) is considered the more prevalent species (in Europe and Patagonia). However, Dibothriocephalus nihonkaiensis (previously Diphyllobothrium nihonkaiensis) is commonly found in East Asian countries, particularly Japan, where diets frequently include raw salmons. The increasing globalization and adoption of diverse dietary practices have led to the detection of tapeworm infections like D. nihonkaiensis outside their traditionally endemic areas, potentially making them more common than previously thought, as exemplified by the present case in Singapore.

Case presentation

A 35-year-old Chinese female presented with chronic abdominal distension, loose stools and unintentional weight loss. 3 months prior to her symptom onset, she had travelled extensively throughout Asia (Thailand, Vietnam, Laos, Malaysia and China) and Mexico and had consumed raw salmon throughout her travels. A full blood count revealed eosinophilia, and a worm was passed during bowel preparation. Molecular sequencing identified it as D. nihonkaiensis. She was treated successfully with praziquantel.

Conclusion

Increased globalization, cross-cultural dietary exchange, and greater salmon consumption have expanded the geographic distribution of D. nihonkaiensis infections beyond previously endemic regions. Consequently, clinicians worldwide must maintain a high index of suspicion for this parasitic infection, even in non-endemic areas. A thorough patient history, with particular attention to dietary habits and travel, is paramount for accurate and timely diagnosis, thereby enabling appropriate treatment and preventing potential complications. Increased awareness, reporting, and molecular identification of Dibothriocephalus are crucial for determining infection sources and guiding food safety surveillance.

Keywords

Abdominal distension Salmon consumption Diphyllobothrium Dibothriocephalus Eosinophilia Praziquantel Cestodes

Background

Species belonging to the genus Dibothriocephalus/Diphyllobothrium represent some of the largest cestodes (tapeworms) capable of infecting humans. Historically, Dibothriocephalus latus (previously Diphyllobothrium latus) is considered the more prevalent species (in Europe and Patagonia). However, Dibothriocephalus nihonkaiensis (formerly Diphyllobothrium nihonkaiensis) is endemic to East Asian countries, notably Japan, where raw salmon consumption is common [1, 2]. The global exchange of dietary practices, including the consumption of raw or poorly cooked salmon, driven by increasing globalisation, suggests that D. nihonkaiensis infections are no longer confined to endemic regions and may be more prevalent than currently appreciated.

Case presentation

A 35-year-old Asian ethnic Chinese female, with a past medical history of gallstones, presented with abdominal distension for 6 months and right sided abdominal pain for 3 months. This was associated with 1 month of loose stools, fatigue and significant (7 kg) unintentional weight loss over the past 3 months. There was no per rectal bleeding, malena or tenesmus. She denied having fever, headache, red eyes, skin lumps, rashes or pruritus ani. 3 months prior to her symptom onset, she had travelled extensively throughout Asia (Thailand, Vietnam, Laos, Malaysia and China) and Mexico and had consumed raw salmon throughout her travels.

Physical examination did not reveal any significant findings. Examination of the cardiorespiratory and abdominal systems were unremarkable.

Full blood count showed 6.81 white blood cells (normal 4.0-9.6 × 103 /µL), 10.7% eosinophilia (0.73 × 103 /µL) (normal 0–7%; 0-0.60 × 103 /µL), haemoglobin level of 15.6 g/dL (normal 11.8–14.6 g/dL) with a mean corpuscular volume 90.7 fL (normal 83.0–98.0 fL), mean corpuscular haemoglobin 32.2 pg (normal 28.0–34.0 pg) and mean corpuscular haemoglobin concentration 35.5 g/dL (normal 33.0–35.0 g/dL). Liver and renal function tests were normal. Microscopic evaluation of 3 stool samples for ova, protozoan cysts and parasites was negative, as were stool polymerase chain reaction for Entamoeba histolytica, Giardia lamblia, Cryptosporidium sp. and Cyclospora cayetanensis.

She was referred for colonoscopy. A worm was passed out during bowel preparation for colonoscopy (Fig. 1A). Colonoscopy did not reveal any worms or abnormalities. A pan-Cestoda PCR targeting a fragment of the mitochondrial ribosomal RNA (16 S rRNA – 12 S rRNA) genes based on a protocol developed by Le and colleagues was attempted [3]. The gene target used for this identification spanned 813 base pairs across the 16 S lsu-rRNA and 12 S ssu-rRNA genes. Basic Local Alignment Search Tool (BLAST) analysis revealed a 99.8% similarity to the reference sequence NC_009463 in the GenBank database. The obtained sequence has been deposited in GenBank under accession number PP102438. The worm was eventually identified as D. nihonkaiensis. Microphotographs of the proglottids and egg are presented in Fig. 1B and C, respectively.

She received a single dose of praziquantel at 10 mg/kg, which led to a prompt resolution of her symptoms. Subsequent stool samples, collected one-month post-treatment, confirmed the absence of eggs.

Discussion and conclusion

Dibothriocephalus nihonkaiensis remains frequently under-recognized in clinical settings due to its significant morphological similarities with D. latus. This diagnostic challenge carries substantial epidemiological implications. Recent genetic studies conducted across Asia, encompassing Korea, Japan, and China, have indeed demonstrated that numerous cases previously diagnosed as D. latus were, upon re-evaluation, identified as D. nihonkaiensis [47].

Beyond this current case, Singapore has documented two additional D. nihonkaiensis infection in 2019 [8]. These occurrences highlight the increasing susceptibility of cosmopolitan societies, characterized by diverse populations and global culinary influences, to the emergence of previously uncommon parasitic infections. In the presented case, precisely pinpointing whether the patient acquired the infection locally in Singapore from imported Pacific salmon may be challenging, given her history of consistent raw salmon consumption during her various frequent international travels. Even so, for accurate diagnosis and epidemiological understanding of tapeworm infections, a detailed dietary history is paramount. By considering the patient’s consumption of raw or undercooked foods and the timing of such ingestion, clinicians may often postulate the likely source and acquisition period of the infection, not only for Dibothriocephalus/Diphyllobothrium species but for cestode infections in general.

Patients infected with Dibothriocephalus/Diphyllobothrium species may present asymptomatically, or manifest with a range of gastrointestinal symptoms including abdominal pain, distension, nausea/vomiting, and diarrhea. Constitutional symptoms such as fatigue, loss of appetite, and weight loss can also occur. Infrequent but serious complications like cholecystitis, cholangitis, pancreatitis, or intestinal obstruction have been reported. Peripheral eosinophilia is occasionally observed [9]. Diagnostic modalities such as colonoscopy and capsule endoscopy can be valuable in detecting these cestodes.

Humans become infected with D. nihonkaiensis through the consumption of raw or undercooked salmonids, which serve as intermediate hosts harbouring the larval plerocercoids [10]. Specifically, Pacific salmon species such as Oncorhynchus masou (cherry salmon) and Oncorhynchus keta (chum salmon) are known to be the second intermediate hosts for D. nihonkaiensis [1012]. In contrast, D. latus infection is typically acquired from freshwater fish such as Perca fluviatilis (Perch) and Esox lucius (Pike) [10].

Historically, D. latus was recognized as the longest human tapeworm. However, adult Dibothriocephalus species, including D. nihonkaiensis, can achieve lengths exceeding 10 m within human hosts [1, 13]. Solely relying on adult worm length for species differentiation is unreliable due to significant overlap and variability. The incubation period for plerocercoids of both D. latus and D. nihonkaiensis typically ranges from 2 to 6 weeks until their development into adult diphyllobothriids in the small intestine [14]. These adult worms can persist in the human host for approximately 10 years or longer.

While D. nihonkaiensis eggs have generally been reported as smaller than those of D. latus, this morphological distinction is not reliable for definitive species diagnosis. A comprehensive study by Choi et al. (2015) demonstrated wide and overlapping variations in both the length and width of eggs between the two species [15]. Consequently, the highly variable egg size of D. nihonkaiensis precludes its use as a specific diagnostic criterion for differentiating diphyllobothriid tapeworm infections in human patients. Other proposed morphological distinctions between Dibothriocephalus subspecies include variations in eggshell shape, the configuration of the genital atrium opening, and the angle between the long axis of the cirrus sac and the seminal vesicles.

However, given the considerable morphological overlap in adult diphyllobothriids and their eggs, molecular identification proves indispensable for definitive species determination. This typically involves sequencing mitochondrial genes such as NADH dehydrogenase subunit 1 (nad1) and cytochrome c oxidase subunit 1 (cox1), as well as 5.8 S ribosomal RNA gene sequences [16, 17]. In this case, DNA sequence analysis of the region (16 S and 12 S RNA genes) encoded by the mitochondrial genome was useful for identifying the diphyllobothriid species.

Praziquantel is the highly effective anthelmintic agent of choice for treating diphyllobothriasis, irrespective of the infecting Dibothriocephalus/Diphyllobothrium species. Niclosamide serves as an alternative therapeutic option. Praziquantel specifically targets and eliminates adult worms; however, it does not exert ovicidal activity. Therefore, stool samples should be re-examined for the presence of eggs approximately one-month post-treatment to confirm parasite clearance. Furthermore, endoscopic removal of the scolex has also been reported as a successful method for achieving disinfestation in diphyllobothriasis cases [18].

In conclusion, this case highlights that D. nihonkaiensis infections can occur in non-endemic areas, likely driven by evolving food consumption patterns, particularly the increased intake of raw salmon. Therefore, there is a critical need to enhance awareness regarding Dibothriocephalus/Diphyllobothrium species infections. We emphasize the importance of reporting all diagnosed cases and rigorously identifying expelled worms, preferably through molecular methods due to morphological similarities. Such comprehensive data collection will be invaluable for pinpointing infection sources, guiding effective food safety surveillance, and ultimately bolstering public health measures against these emerging parasitic pathogens.

https://static-content.springer.com/image/art%3A10.1186%2Fs13099-025-00738-9/MediaObjects/13099_2025_738_Fig1_HTML.png
Fig. 1

(A) Worm expelled from patient (B) Microphotograph of D. nihonkaiensis proglottids (width 5.4 mm x thickness 2.1 mm) with a uterus filled with eggs and genital pore (C) Iodine wet mount specimen of the egg from D. nihonkaiensis

Acknowledgements

We would like to express our deepest appreciation to the Department of Microbiology (National University Health System and Tan Tock Seng Hospital) and National Public Health Laboratory for providing their expert opinion and images for conditions not routinely encountered in our clinical practice.

Declarations

Not applicable.

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.

Competing interests

The authors declare no competing interests.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Download
Titel
Dietary footprints of a global parasite: diagnosing Dibothriocephalus nihonkaiensis in non-endemic regions
Verfasst von
Wilson G.W. Goh
Jean-Marc Chavatte
Gabriel Z.R. Yan
Yuan Yi Constance Chen
Mark Dhinesh Muthiah
Lionel H.W. Lum
Publikationsdatum
01.12.2025
Verlag
BioMed Central
Erschienen in
Gut Pathogens / Ausgabe 1/2025
Elektronische ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-025-00738-9
  1. Ikuno H, Akao S, Yamasaki H. Epidemiology of diphyllobothrium Nihonkaiense diphyllobothriasis, japan, 2001–2016. Emerg Infect Dis. 2018;24(8):1428–34.PubMedPubMed CentralView Article
  2. Tsuboi M, Hayakawa K, Yamasaki H, Katanami Y, Yamamoto K, Kutsuna S, Takeshita N, Kanagawa S, Ohmagari N, Kato Y. Clinical characteristics and epidemiology of intestinal tapeworm infections over the last decade in tokyo, japan: A retrospective review. PLoS Negl Trop Dis. 2018;12(2):e0006297.PubMedPubMed CentralView Article
  3. Le TH, Blair D, McManus DP. Mitochondrial genomes of parasitic flatworms. Trends Parasitol. 2002;18(5):206–13.PubMedView Article
  4. Park SH, Jeon HK, Kim JB. Four additional cases of diphyllobothrium Nihonkaiense infection confirmed by analysis of COX1 gene in Korea. Korean J Parasitol. 2015;53(1):105–8.PubMedPubMed CentralView Article
  5. Chen S, Ai L, Zhang Y, Chen J, Zhang W, Li Y, Muto M, Morishima Y, Sugiyama H, Xu X, Zhou X, Yamasaki H. Molecular detection of Diphyllobothrium Nihonkaiense in humans. China Emerg Infect Dis. 2014;20(2):315–8.PubMedView Article
  6. Zhang W, Che F, Tian S, Shu J, Zhang X. Molecular identification of Diphyllobothrium Nihonkaiense from 3 human cases in Heilongjiang Province with a brief literature review in China. Korean J Parasitol. 2015;53(6):683–8.PubMedPubMed CentralView Article
  7. Cai YC, Chen SH, Yamasaki H, Chen JX, Lu Y, Zhang YN, Li H, Ai L, Chen HN. Four human cases of Diphyllobothrium Nihonkaiense (Eucestoda: Diphyllobothriidae) in China with a brief review of Chinese cases. Korean J Parasitol. 2017;55(3):319–25.PubMedPubMed CentralView Article
  8. Ko KKK, Cao DYH, Wee LWY, Hsu LY, Yamasaki H. First two confirmed cases of Dibothriocephalus nihonkaiensis in Southeast Asia (Singapore). Pathology. 2019;51(4):433–4.PubMedView Article
  9. Arizono N, Yamada M, Nakamura-Uchiyama F, Ohnishi K. Diphyllobothriasis associated with eating Raw Pacific salmon. Emerg Infect Dis. 2009;15(6):866–70.PubMedPubMed CentralView Article
  10. Cabello FC. Salmon aquaculture and transmission of the fish tapeworm. Emerg Infect Dis. 2007;13(1):169–71.PubMedPubMed CentralView Article
  11. Paugam A, Yéra H. A new French case of Dibothriocephalus nihonkaiensis (Diphyllobothrium nihonkaiense) teniasis due to Pacific salmon consumption: an emerging and underdiagnosed parasitosis. Infect Dis now. 2021;51(6):579–80.PubMedView Article
  12. Suzuki J, Murata R, Sadamasu K, Araki J. Detection and identification of Diphyllobothrium Nihonkaiense plerocercoids from wild Pacific salmon (Oncorhynchus spp.) in Japan. J Helminthol. 2010;84(4):434–40.PubMedView Article
  13. Scholz T, Garcia HH, Kuchta R, Wicht B. Update on the human broad tapeworm (genus diphyllobothrium), including clinical relevance. Clin Microbiol Rev. 2009;22(1):146–60.PubMedPubMed CentralView Article
  14. Go YB, Lee EH, Cho J, Choi S, Chai JY. Diphyllobothrium Nihonkaiense infections in a family. Korean J Parasitol. 2015;53(1):109–12.PubMedPubMed CentralView Article
  15. Choi S, Cho J, Jung BK, Kim DG, Jeon SJ, Jeon HK, Eom KS, Chai JY. Diphyllobothrium nihonkaiense: wide egg size variation in 32 molecularly confirmed adult specimens from Korea. Parasitol Res. 2015;114(6):2129–34.PubMedView Article
  16. Park SH, Eom KS, Park MS, Kwon OK, Kim HS, Yoon JH. A case of Diphyllobothrium Nihonkaiense infection as confirmed by mitochondrial COX1 gene sequence analysis. Korean J Parasitol. 2013;51(4):471–3.PubMedPubMed CentralView Article
  17. Jeon HK, Kim KH, Huh S, Chai JY, Min DY, Rim HJ, Eom KS. Morphologic and genetic identification of Diphyllobothrium Nihonkaiense in Korea. Korean J Parasitol. 2009;47(4):369–75.PubMedPubMed CentralView Article
  18. Kida A, Matsuda M, Sakai A. Endoscopic therapy of jejunal Diphyllobothrium Nihonkaiense infection. Clin Gastroenterol Hepatol. 2018;16(10):e101–2.PubMedView Article

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Fokale Salvage-Therapie bei lokalem Prostatakrebsrezidiv langfristig wirksam

Bei einem nach Radiotherapie lokal rezidivierten Prostatakarzinom sind fokale Salvage-Therapien mit einer guten Prognose verbunden: Das krebsspezifische Zehn-Jahres-Überleben ist einem retrospektiven Vergleich zufolge ebenso hoch wie nach Salvage-Prostatektomie.

Relacorilant verlängert Überleben bei platinresistentem Ovarialkarzinom

Durch Hinzunahme des Glukokortikoid-Rezeptor-Antagonisten Relacorilant zu nab-Paclitaxel wird bei Frauen mit platinresistentem Ovarialkarzinom nicht nur das progressionsfreie, sondern auch das Gesamtüberleben verlängert. Laut finaler Analyse der ROSELLA-Studie gewinnen sie vier Monate an Lebenszeit.

ICI-induzierte Dermatitis: Upadacitinib als vielversprechende Therapieoption

Immunvermittelte Hautreaktionen gehören zu den häufigsten Nebenwirkungen von Immun‑Checkpoint‑Inhibitoren. Eine offene Phase‑2‑Studie untersuchte den JAK‑1‑Inhibitor Upadacitinib bei schwerer ICI‑assoziierter Dermatitis. Die Hautsymptome gingen rasch zurück, schwerwiegende therapieassoziierte Nebenwirkungen wurden nicht beobachtet.

Extrapulmonale Befunde beim Lungenkrebs-Screening – Krebsverdacht gerechtfertigt?

Der Umgang mit Zufallsentdeckungen ist ein vieldiskutiertes Thema im Zusammenhang mit dem Low-Dose-CT-Screening auf Lungenkrebs. Eine Studie hat sich nun speziell mit inzidentellen Befunden befasst, die auf ein extrapulmonales Malignom verdächtig sind.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Eine Person kratzt sich am Rücken über der Schulter/© ryanking999 / stock.adobe.com (Symbolbild mit Fotomodell), Mann erhält einen CT-Scan /© Mark Kostich / stock.adobe.com (Symbolbild mit Fotomodell)